Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haopeng Sun

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Journal of Medicinal Chemistry|March 27, 2025
Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular CarcinomaShuaishuai Xing, Jiheng Jiang, Xianglin Chu, et al.
European Journal of Medicinal Chemistry|February 18, 2026
A strategy for improving blood-brain barrier permeability of ChE inhibitors through blood-brain barrier (BBB) transporterZiming Gao, Yanyu Hu, Na Zheng, et al.
European Journal of Medicinal Chemistry|July 2, 2026
Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosisYuanyuan Wang, Jingjing Sang, Hongtao Li, et al.
Chemico-Biological Interactions|July 25, 2025
Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's diseaseUrban Košak, Damijan Knez, Svit Ferjančič Benetik, et al.
Journal of Medicinal Chemistry|August 15, 2022
<i>N</i>-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's DiseaseChenxi Du, Lei Wang, Qianwen Guan, et al.
Biomaterials Research|April 20, 2026
Nanoparticle-Loaded Injectable Hydrogel Alleviates Titanium Particle-Induced Osteolysis by Disrupting GATA6/DDX3X-Mediated Macrophage InflammationSipeng Lin, Taihe Liu, Qi Zhu, et al.
Journal of Medicinal Chemistry|July 6, 2023
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer TreatmentSiyu He, Xianglin Chu, Yujia Wu, et al.
Journal of the American Chemical Society|March 14, 2024
Direct Synthesis of α- and β-2'-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote ParticipationXintong Tang, Yueer Zhou, Yingjie Wang, et al.
Journal of Medicinal Chemistry|June 2, 2025
Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's DiseaseUrban Košak, Nika Strašek Benedik, Damijan Knez, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Journal of Medicinal Chemistry|March 27, 2025
Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular CarcinomaShuaishuai Xing, Jiheng Jiang, Xianglin Chu, et al.
European Journal of Medicinal Chemistry|February 18, 2026
A strategy for improving blood-brain barrier permeability of ChE inhibitors through blood-brain barrier (BBB) transporterZiming Gao, Yanyu Hu, Na Zheng, et al.
European Journal of Medicinal Chemistry|July 2, 2026
Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosisYuanyuan Wang, Jingjing Sang, Hongtao Li, et al.
Chemico-Biological Interactions|July 25, 2025
Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's diseaseUrban Košak, Damijan Knez, Svit Ferjančič Benetik, et al.
Journal of Medicinal Chemistry|August 15, 2022
<i>N</i>-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's DiseaseChenxi Du, Lei Wang, Qianwen Guan, et al.
Biomaterials Research|April 20, 2026
Nanoparticle-Loaded Injectable Hydrogel Alleviates Titanium Particle-Induced Osteolysis by Disrupting GATA6/DDX3X-Mediated Macrophage InflammationSipeng Lin, Taihe Liu, Qi Zhu, et al.
Journal of Medicinal Chemistry|July 6, 2023
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer TreatmentSiyu He, Xianglin Chu, Yujia Wu, et al.
Journal of the American Chemical Society|March 14, 2024
Direct Synthesis of α- and β-2'-Deoxynucleosides with Stereodirecting Phosphine Oxide via Remote ParticipationXintong Tang, Yueer Zhou, Yingjie Wang, et al.
Journal of Medicinal Chemistry|June 2, 2025
Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's DiseaseUrban Košak, Nika Strašek Benedik, Damijan Knez, et al.
Pageof 17